
Sign up to save your podcasts
Or


This week, please join author Mathew S. Maurer as he discusses the article "Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20260126.13097
By Greg Hundley, MD and Peder Myhre, MD, PhD4.3
3030 ratings
This week, please join author Mathew S. Maurer as he discusses the article "Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20260126.13097

138 Listeners

320 Listeners

500 Listeners

166 Listeners

899 Listeners

298 Listeners

3,376 Listeners

136 Listeners

1,150 Listeners

196 Listeners

91 Listeners

515 Listeners

369 Listeners

431 Listeners

372 Listeners